{"id":29443,"date":"2023-07-19T10:23:15","date_gmt":"2023-07-19T14:23:15","guid":{"rendered":"https:\/\/www.cancerresearch.org\/?post_type=cri_news&#038;p=29443"},"modified":"2023-07-19T13:56:14","modified_gmt":"2023-07-19T17:56:14","slug":"surge-therapeutics-raises-32m-series-b-financing-to-advance-intraoperativeimmunotherapy-to-improve-cancer-patient-survival-outcomes-post-surgery","status":"publish","type":"cri_news","link":"https:\/\/www.cancerresearch.org\/es\/media-room\/surge-therapeutics-raises-32m-series-b-financing-to-advance-intraoperativeimmunotherapy-to-improve-cancer-patient-survival-outcomes-post-surgery","title":{"rendered":"SURGE Therapeutics Raises $32M Series B Financing to Advance IntraoperativeImmunotherapy to Improve Cancer Patient Survival Outcomes Post-Surgery"},"content":{"rendered":"","protected":false},"excerpt":{"rendered":"","protected":false},"featured_media":29457,"template":"","tags":[],"resource_cancer_types":[],"resource_patient_age":[],"resource_cancer_stage":[],"resource_treatment_type":[],"resource_treatment_status":[],"class_list":["post-29443","cri_news","type-cri_news","status-publish","has-post-thumbnail","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>SURGE Therapeutics Raises $32M Series B Financing to Advance IntraoperativeImmunotherapy to Improve Cancer Patient Survival Outcomes Post-Surgery - Cancer Research Institute<\/title>\n<meta name=\"description\" content=\"SURGE Therapeutics raises $32 million for immunotherapy to improve cancer survival outcomes after surgery.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.cancerresearch.org\/media-room\/surge-therapeutics-raises-32m-series-b-financing-to-advance-intraoperativeimmunotherapy-to-improve-cancer-patient-survival-outcomes-post-surgery\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"SURGE Therapeutics Raises $32M Series B Financing to Advance IntraoperativeImmunotherapy to Improve Cancer Patient Survival Outcomes Post-Surgery - Cancer Research Institute\" \/>\n<meta property=\"og:description\" content=\"SURGE Therapeutics raises $32 million for immunotherapy to improve cancer survival outcomes after surgery.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.cancerresearch.org\/media-room\/surge-therapeutics-raises-32m-series-b-financing-to-advance-intraoperativeimmunotherapy-to-improve-cancer-patient-survival-outcomes-post-surgery\" \/>\n<meta property=\"og:site_name\" content=\"Cancer Research Institute\" \/>\n<meta property=\"article:modified_time\" content=\"2023-07-19T17:56:14+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2023\/07\/SURGE-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"440\" \/>\n\t<meta property=\"og:image:height\" content=\"440\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.cancerresearch.org\/media-room\/surge-therapeutics-raises-32m-series-b-financing-to-advance-intraoperativeimmunotherapy-to-improve-cancer-patient-survival-outcomes-post-surgery\",\"url\":\"https:\/\/www.cancerresearch.org\/media-room\/surge-therapeutics-raises-32m-series-b-financing-to-advance-intraoperativeimmunotherapy-to-improve-cancer-patient-survival-outcomes-post-surgery\",\"name\":\"SURGE Therapeutics Raises $32M Series B Financing to Advance IntraoperativeImmunotherapy to Improve Cancer Patient Survival Outcomes Post-Surgery - Cancer Research Institute\",\"isPartOf\":{\"@id\":\"https:\/\/www.cancerresearch.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.cancerresearch.org\/media-room\/surge-therapeutics-raises-32m-series-b-financing-to-advance-intraoperativeimmunotherapy-to-improve-cancer-patient-survival-outcomes-post-surgery#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.cancerresearch.org\/media-room\/surge-therapeutics-raises-32m-series-b-financing-to-advance-intraoperativeimmunotherapy-to-improve-cancer-patient-survival-outcomes-post-surgery#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2023\/07\/SURGE-1.jpg\",\"datePublished\":\"2023-07-19T14:23:15+00:00\",\"dateModified\":\"2023-07-19T17:56:14+00:00\",\"description\":\"SURGE Therapeutics raises $32 million for immunotherapy to improve cancer survival outcomes after surgery.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.cancerresearch.org\/media-room\/surge-therapeutics-raises-32m-series-b-financing-to-advance-intraoperativeimmunotherapy-to-improve-cancer-patient-survival-outcomes-post-surgery#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.cancerresearch.org\/media-room\/surge-therapeutics-raises-32m-series-b-financing-to-advance-intraoperativeimmunotherapy-to-improve-cancer-patient-survival-outcomes-post-surgery\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cancerresearch.org\/media-room\/surge-therapeutics-raises-32m-series-b-financing-to-advance-intraoperativeimmunotherapy-to-improve-cancer-patient-survival-outcomes-post-surgery#primaryimage\",\"url\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2023\/07\/SURGE-1.jpg\",\"contentUrl\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2023\/07\/SURGE-1.jpg\",\"width\":440,\"height\":440},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.cancerresearch.org\/media-room\/surge-therapeutics-raises-32m-series-b-financing-to-advance-intraoperativeimmunotherapy-to-improve-cancer-patient-survival-outcomes-post-surgery#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.cancerresearch.org\/es\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Media Room Article\",\"item\":\"https:\/\/www.cancerresearch.org\/media-room\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"SURGE Therapeutics Raises $32M Series B Financing to Advance IntraoperativeImmunotherapy to Improve Cancer Patient Survival Outcomes Post-Surgery\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cancerresearch.org\/#website\",\"url\":\"https:\/\/www.cancerresearch.org\/\",\"name\":\"Cancer Research Institute\",\"description\":\"For a World Immune to Cancer\",\"publisher\":{\"@id\":\"https:\/\/www.cancerresearch.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cancerresearch.org\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cancerresearch.org\/#organization\",\"name\":\"Cancer Research Institute\",\"url\":\"https:\/\/www.cancerresearch.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg\",\"contentUrl\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg\",\"width\":156,\"height\":53,\"caption\":\"Cancer Research Institute\"},\"image\":{\"@id\":\"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"SURGE Therapeutics Raises $32M Series B Financing to Advance IntraoperativeImmunotherapy to Improve Cancer Patient Survival Outcomes Post-Surgery - Cancer Research Institute","description":"SURGE Therapeutics raises $32 million for immunotherapy to improve cancer survival outcomes after surgery.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.cancerresearch.org\/media-room\/surge-therapeutics-raises-32m-series-b-financing-to-advance-intraoperativeimmunotherapy-to-improve-cancer-patient-survival-outcomes-post-surgery","og_locale":"es_ES","og_type":"article","og_title":"SURGE Therapeutics Raises $32M Series B Financing to Advance IntraoperativeImmunotherapy to Improve Cancer Patient Survival Outcomes Post-Surgery - Cancer Research Institute","og_description":"SURGE Therapeutics raises $32 million for immunotherapy to improve cancer survival outcomes after surgery.","og_url":"https:\/\/www.cancerresearch.org\/media-room\/surge-therapeutics-raises-32m-series-b-financing-to-advance-intraoperativeimmunotherapy-to-improve-cancer-patient-survival-outcomes-post-surgery","og_site_name":"Cancer Research Institute","article_modified_time":"2023-07-19T17:56:14+00:00","og_image":[{"width":440,"height":440,"url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2023\/07\/SURGE-1.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.cancerresearch.org\/media-room\/surge-therapeutics-raises-32m-series-b-financing-to-advance-intraoperativeimmunotherapy-to-improve-cancer-patient-survival-outcomes-post-surgery","url":"https:\/\/www.cancerresearch.org\/media-room\/surge-therapeutics-raises-32m-series-b-financing-to-advance-intraoperativeimmunotherapy-to-improve-cancer-patient-survival-outcomes-post-surgery","name":"SURGE Therapeutics Raises $32M Series B Financing to Advance IntraoperativeImmunotherapy to Improve Cancer Patient Survival Outcomes Post-Surgery - Cancer Research Institute","isPartOf":{"@id":"https:\/\/www.cancerresearch.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.cancerresearch.org\/media-room\/surge-therapeutics-raises-32m-series-b-financing-to-advance-intraoperativeimmunotherapy-to-improve-cancer-patient-survival-outcomes-post-surgery#primaryimage"},"image":{"@id":"https:\/\/www.cancerresearch.org\/media-room\/surge-therapeutics-raises-32m-series-b-financing-to-advance-intraoperativeimmunotherapy-to-improve-cancer-patient-survival-outcomes-post-surgery#primaryimage"},"thumbnailUrl":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2023\/07\/SURGE-1.jpg","datePublished":"2023-07-19T14:23:15+00:00","dateModified":"2023-07-19T17:56:14+00:00","description":"SURGE Therapeutics raises $32 million for immunotherapy to improve cancer survival outcomes after surgery.","breadcrumb":{"@id":"https:\/\/www.cancerresearch.org\/media-room\/surge-therapeutics-raises-32m-series-b-financing-to-advance-intraoperativeimmunotherapy-to-improve-cancer-patient-survival-outcomes-post-surgery#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.cancerresearch.org\/media-room\/surge-therapeutics-raises-32m-series-b-financing-to-advance-intraoperativeimmunotherapy-to-improve-cancer-patient-survival-outcomes-post-surgery"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cancerresearch.org\/media-room\/surge-therapeutics-raises-32m-series-b-financing-to-advance-intraoperativeimmunotherapy-to-improve-cancer-patient-survival-outcomes-post-surgery#primaryimage","url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2023\/07\/SURGE-1.jpg","contentUrl":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2023\/07\/SURGE-1.jpg","width":440,"height":440},{"@type":"BreadcrumbList","@id":"https:\/\/www.cancerresearch.org\/media-room\/surge-therapeutics-raises-32m-series-b-financing-to-advance-intraoperativeimmunotherapy-to-improve-cancer-patient-survival-outcomes-post-surgery#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.cancerresearch.org\/es"},{"@type":"ListItem","position":2,"name":"Media Room Article","item":"https:\/\/www.cancerresearch.org\/media-room"},{"@type":"ListItem","position":3,"name":"SURGE Therapeutics Raises $32M Series B Financing to Advance IntraoperativeImmunotherapy to Improve Cancer Patient Survival Outcomes Post-Surgery"}]},{"@type":"WebSite","@id":"https:\/\/www.cancerresearch.org\/#website","url":"https:\/\/www.cancerresearch.org\/","name":"Cancer Research Institute","description":"For a World Immune to Cancer","publisher":{"@id":"https:\/\/www.cancerresearch.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cancerresearch.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.cancerresearch.org\/#organization","name":"Cancer Research Institute","url":"https:\/\/www.cancerresearch.org\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg","contentUrl":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg","width":156,"height":53,"caption":"Cancer Research Institute"},"image":{"@id":"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/cri_news\/29443","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/cri_news"}],"about":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/types\/cri_news"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/media\/29457"}],"wp:attachment":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/media?parent=29443"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/tags?post=29443"},{"taxonomy":"resource_cancer_types","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_cancer_types?post=29443"},{"taxonomy":"resource_patient_age","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_patient_age?post=29443"},{"taxonomy":"resource_cancer_stage","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_cancer_stage?post=29443"},{"taxonomy":"resource_treatment_type","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_treatment_type?post=29443"},{"taxonomy":"resource_treatment_status","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_treatment_status?post=29443"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}